National registry insights on genetic aortopathies and thoracic endovascular aortic interventions
Journal of Vascular Surgery · 2024
DOI: 10.1016/j.jvs.2024.05.002 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Vascular Surgery, 2024. Verfasst von Jorge L Gomez-Mayorga und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Endovascular Procedures, Registries, Blood Vessel Prosthesis Implantation, Postoperative Complications. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: NHLBI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) in patients with genetic aortopathies (GA) is controversial, given concerns of durability. We describe characteristics and outcomes after TEVAR in patients with GA. METHODS: All patients undergoing TEVAR between 2010 and 2023 in the Vascular Quality Iniatitive were identified and categorized as having a GA or not. Demographics, baseline, and procedural characteristics were compared among groups. Multivariable logistic regression was used to evaluate the independent association of GA with postoperative outcomes. Kaplan-Meier methods and multivariable Cox regression analyses were used to evaluate 5-year survival and 2-year reinterventions. RESULTS: Of 19,340 patients, 304 (1.6%) had GA (87% Marfan syndrome, 9% Loeys-Dietz syndrome, and 4% vascular Ehlers-Danlos syndrome). Compared with patients without GA, patients with GA were younger (50 years [interquartile range, 37-72 years] vs 70 years [interquartile range, 61-77 years]), more often presented with acute dissection (28% vs 18%), postdissection aneurysm (48% vs 17%), had a symptomatic presentation (50% vs 39%), and were less likely to have degenerative aneurysms (18% vs 47%) or penetrating aortic ulcer (and intramural hematoma) (3% vs 13%) (all P < .001). Patients with GA were more likely to have prior repair of the ascending aorta/arch (open, 56% vs 11% [P < .001]; endovascular, 5.6% vs 2.1% [P = .017]) or the descending thoracic aorta (open, 12% vs 2% [P = .007]; endovascular, 8.2% vs 3.6% [P = .011]). No significant differences were found in prior abdominal suprarenal repairs; however, patients with GA had more prior open infrarenal repairs (5.3% vs 3.2%), but fewer prior endovascular infrarenal repairs (3.3% vs 5.5%) (all P < .05). After adjusting for demographics, comorbidities, and disease characteristics, patients with GA had similar odds of perioperative mortality (4.6% vs 7.0%; adjusted odds ratio [aOR], 1.1; 95% confidence interval [CI], 0.57-1.9; P = .75), any in-hospital complication (26% vs 23%; aOR, 1.24; 95% CI, 0.92-1.6; P = .14), or in-hospital reintervention (13% vs 8.3%; aOR, 1.25; 95% CI, 0.84-1.80; P = .25) compared with patients without GA. However, patients with GA had a higher likelihood of postoperative vasopressors (33% vs 27%; aOR, 1.44; 95% CI, 1.1-1.9; P = .006) and transfusion (25% vs 23%; aOR, 1.39; 95% CI, 1.03-1.9; P = .006). The 2-year reintervention rates were higher in patients with GA (25% vs 13%; adjusted hazard ratio, 1.99; 95% CI, 1.4-2.9; P < .001), but 5-year survival was similar (81% vs 74%; adjusted hazard ratio, 1.02; 95% CI, 0.70-1.50; P = .1). CONCLUSIONS: TEVAR for patients with GA seemed to be safe initially, with similar odds for in-hospital complications, in-hospital reinterventions, and perioperative mortality, as well as similar hazards for 5-year mortality compared with patients without GA. However, patients with GA had higher 2-year reintervention rates. Future studies should assess long-term durability after TEVAR compared with the recommended open repair to appropriately weigh the risks and benefits of endovascular treatment in patients with GA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
- Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Section of Vascular Surgery, Cardio Thoracic Vascular Department, Foundatio…
- Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Division of Vascular & Endovascular Surgery, Department of Surgery, UC San…
- Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
- Division of Vascular and Endovascular Surgery, University of Washington, Seattle, WA.
- Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: mscherme@bidmc.harvard.edu.
Förderung
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Gomez-Mayorga, J. L., Yadavalli, S. D., Allievi, S., Wang, S. X., Rastogi, V., Straus, S., Mandigers, T. J., Black, J. H., Zettervall, S. L., & Schermerhorn, M. L. (2024). National registry insights on genetic aortopathies and thoracic endovascular aortic interventions. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.05.002
Vancouver
Gomez-Mayorga JL, Yadavalli SD, Allievi S, Wang SX, Rastogi V, Straus S, et al. National registry insights on genetic aortopathies and thoracic endovascular aortic interventions. Journal of Vascular Surgery. 2024. doi:10.1016/j.jvs.2024.05.002
BibTeX
@article{GomezMayorga2024,
author = {Gomez-Mayorga, Jorge L and Yadavalli, Sai Divya and Allievi, Sara and Wang, Sophie X and Rastogi, Vinamr and Straus, Sabrina and Mandigers, Tim J and Black, James H and Zettervall, Sara L and Schermerhorn, Marc L},
title = {National registry insights on genetic aortopathies and thoracic endovascular aortic interventions},
journal = {Journal of Vascular Surgery},
year = {2024},
doi = {10.1016/j.jvs.2024.05.002}
}
EUVIMED